OBJECTIVE: To evaluate the performance of a newly developed point-of-care test (POCT) for the detection of measles-specific IgM antibodies in serum and oral fluid specimens and to assess if measles virus nucleic acid could be recovered from used POCT strips. METHODS: The POCT was used to test 170 serum specimens collected through measles surveillance or vaccination programmes in Ethiopia, Malaysia and the Russian Federation: 69 were positive for measles immunoglobulin M (IgM) antibodies, 74 were positive for rubella IgM antibodies and 7 were positive for both. Also tested were 282 oral fluid specimens from the measles, mumps and rubella (MMR) surveillance programme of the United Kingdom of Great Britain and Northern Ireland. The Microimmune measles IgM capture enzyme immunoassay was the gold standard for comparison. A panel of 24 oral fluids was used to investigate if measles virus haemagglutinin (H) and nucleocapsid (N) genes could be amplified by polymerase chain reaction directly from used POCT strips. FINDINGS: With serum POCT showed a sensitivity and specificity of 90.8% (69/76) and 93.6% (88/94), respectively; with oral fluids, sensitivity and specificity were 90.0% (63/70) and 96.2% (200/208), respectively. Both H and N genes were reliably detected in POCT strips and the N genes could be sequenced for genotyping. Measles virus genes could be recovered from POCT strips after storage for 5 weeks at 20-25 °C. CONCLUSION: The POCT has the sensitivity and specificity required of a field-based test for measles diagnosis. However, its role in global measles control programmes requires further evaluation.
OBJECTIVE: To evaluate the performance of a newly developed point-of-care test (POCT) for the detection of measles-specific IgM antibodies in serum and oral fluid specimens and to assess if measles virus nucleic acid could be recovered from used POCT strips. METHODS: The POCT was used to test 170 serum specimens collected through measles surveillance or vaccination programmes in Ethiopia, Malaysia and the Russian Federation: 69 were positive for measles immunoglobulin M (IgM) antibodies, 74 were positive for rubella IgM antibodies and 7 were positive for both. Also tested were 282 oral fluid specimens from the measles, mumps and rubella (MMR) surveillance programme of the United Kingdom of Great Britain and Northern Ireland. The Microimmune measles IgM capture enzyme immunoassay was the gold standard for comparison. A panel of 24 oral fluids was used to investigate if measles virus haemagglutinin (H) and nucleocapsid (N) genes could be amplified by polymerase chain reaction directly from used POCT strips. FINDINGS: With serum POCT showed a sensitivity and specificity of 90.8% (69/76) and 93.6% (88/94), respectively; with oral fluids, sensitivity and specificity were 90.0% (63/70) and 96.2% (200/208), respectively. Both H and N genes were reliably detected in POCT strips and the N genes could be sequenced for genotyping. Measles virus genes could be recovered from POCT strips after storage for 5 weeks at 20-25 °C. CONCLUSION: The POCT has the sensitivity and specificity required of a field-based test for measles diagnosis. However, its role in global measles control programmes requires further evaluation.
Authors: Dhanraj Samuel; Kestutis Sasnauskas; Li Jin; Alma Gedvilaite; Rimas Slibinskas; Stuart Beard; Aurelija Zvirbliene; Solange Artimos Oliveira; Juozas Staniulis; Bernard Cohen; David Brown Journal: J Clin Virol Date: 2003-10 Impact factor: 3.168
Authors: David W Brown; Lenesha Warrener; Heather M Scobie; Morgane Donadel; Diane Waku-Kouomou; Mick N Mulders; Paul A Rota Journal: Curr Opin Virol Date: 2020-06-29 Impact factor: 7.090
Authors: A Shonhai; L Warrener; D Mangwanya; R Slibinskas; K Brown; D Brown; D Featherstone; D Samuel Journal: Epidemiol Infect Date: 2015-04-13 Impact factor: 4.434
Authors: Henri Garrison-Desany; Benard Omondi Ochieng; Maurice R Odiere; Helen Kuo; Dustin G Gibson; Joyce Were; E Wangeci Kagucia; Marcela F Pasetti; Hani Kim; Mardi Reymann; Katherine O'Brien; Kyla Hayford Journal: Vaccine Date: 2020-11-27 Impact factor: 3.641
Authors: Paul A Gastañaduy; Emily Banerjee; Chas DeBolt; Pamela Bravo-Alcántara; Samia A Samad; Desiree Pastor; Paul A Rota; Manisha Patel; Natasha S Crowcroft; David N Durrheim Journal: Hum Vaccin Immunother Date: 2018-07-11 Impact factor: 3.452
Authors: Andrea C Carcelen; Kyla Hayford; William J Moss; Christopher Book; Philip E Thuma; Francis D Mwansa; Bryan Patenaude Journal: PLoS One Date: 2020-10-15 Impact factor: 3.240